Monday, April 27, 2015 12:17:48 PM
And remember this is not a new ground breaking technology or breakthrough Biotech stock looking at explosive growth. It's a no nothing, unbranded and unknown consumer product in a crowded space with no differentiation and tiny margins with a relatively high COG. And 2 billion shares out on MRIB is a HUGE number for a company that makes $2,000 a month. It's absurd to even consider MRIB an ongoing concern.
And this Brazil thing is also absurd. I have yet to hear any explanation of why or how MRIB could sell in Brazil when they can't sell in their own backyard? How's that going to happen? If the product doesn't sell here it won't sell there. That's just fact.
FEATURED Cannabix's Breath Logix Alcohol Device Delivers Positive Impact to Private Monitoring Agency in Montana, USA • Apr 25, 2024 8:52 AM
Bantec Reports an Over 50 Percent Increase in Sales and Profits in Q1 2024 from Q1 2023 • BANT • Apr 25, 2024 10:00 AM
Kona Gold Beverages, Inc. Announces Name Change to NuVibe, Inc. and Initiation of Ticker Symbol Application Process • KGKG • Apr 25, 2024 8:30 AM
Axis Technologies Group and Carbonis Forge Ahead with New Digital Carbon Credit Technology • AXTG • Apr 24, 2024 3:00 AM
North Bay Resources Announces Successful Equipment Test at Bishop Gold Mill, Inyo County, California • NBRI • Apr 23, 2024 9:41 AM
Epazz, Inc.: CryObo, Inc. solar Bitcoin operations will issue tokens • EPAZ • Apr 23, 2024 9:20 AM